Purchase Order 75N93020P00012

This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research and public health, including gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services. Many of Genscript's contracts have supported the rapid development of research materials in response to emerging infectious disease threats. While this award has no set-aside designation, Genscript has received some small business set-aside contracts from the NIH and USDA. Genscript also holds a $1.5 million blanket purchase agreement with the USDA's Animal and Plant Health Inspection Service to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents.